Hezhen Medicine
Latest round
- Series B
Last raised
- Nov 2025
Total raised
- Undisclosed
Investors
- 2
About Hezhen Medicine
, dba Hezhen Medicine, integrates drug discovery, process development, and formulation innovation. The company has established research platforms for new drug delivery systems and druggability evaluation, driving innovation in sustained and controlled-release technologies and novel chemical entities. Hezhen Medicine engages in the development of innovative and generic drugs, with expertise in sustained-release formulations and synthesis process optimization. Its product portfolio focuses on immuno-oncology and liver disease therapeutics, supported by in-house R&D, technology transfer, and production capabilities. The company generates revenue from the development and commercialization of proprietary drug formulations, technology transfer, contract research services, and product sales in the biopharmaceutical sector.
Who invested in Hezhen Medicine
2 investors across 2 rounds
See all investors in Hezhen Medicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hezhen Medicine
Who invested in Hezhen Medicine?
Hezhen Medicine has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hezhen Medicine raised?
Hezhen Medicine has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Hezhen Medicine last raise money?
Hezhen Medicine's most recent round on record is a Series B, in Nov 2025.
What does Hezhen Medicine do?
, dba Hezhen Medicine, integrates drug discovery, process development, and formulation innovation.
Where is Hezhen Medicine headquartered?
Hezhen Medicine is headquartered in Hangzhou, China.
Which VCs invest in companies like Hezhen Medicine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Hezhen Medicine's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Hezhen Medicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.